6OM Stock Overview
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Owens & Minor, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$22.80 |
52 Week High | US$25.80 |
52 Week Low | US$12.20 |
Beta | 0.47 |
1 Month Change | -3.39% |
3 Month Change | 25.97% |
1 Year Change | 62.86% |
3 Year Change | -26.97% |
5 Year Change | 641.46% |
Change since IPO | 24.50% |
Recent News & Updates
Recent updates
Shareholder Returns
6OM | DE Healthcare | DE Market | |
---|---|---|---|
7D | -4.2% | 3.7% | -2.0% |
1Y | 62.9% | -3.9% | -0.3% |
Return vs Industry: 6OM exceeded the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: 6OM exceeded the German Market which returned -0.3% over the past year.
Price Volatility
6OM volatility | |
---|---|
6OM Average Weekly Movement | 5.3% |
Healthcare Industry Average Movement | 5.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6OM's share price has been volatile over the past 3 months.
Volatility Over Time: 6OM's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1882 | 22,200 | Ed Pesicka | www.owens-minor.com |
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Owens & Minor, Inc. Fundamentals Summary
6OM fundamental statistics | |
---|---|
Market cap | €1.78b |
Earnings (TTM) | -€38.77m |
Revenue (TTM) | €9.70b |
0.2x
P/S Ratio-44.9x
P/E RatioIs 6OM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6OM income statement (TTM) | |
---|---|
Revenue | US$10.33b |
Cost of Revenue | US$8.12b |
Gross Profit | US$2.22b |
Other Expenses | US$2.26b |
Earnings | -US$41.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 03, 2024
Earnings per share (EPS) | -0.54 |
Gross Margin | 21.46% |
Net Profit Margin | -0.40% |
Debt/Equity Ratio | 225.6% |
How did 6OM perform over the long term?
See historical performance and comparison